Oral corticosteroid elimination via a personalised reduction algorithm in adults with severe, eosinophilic asthma treated with benralizumab (PONENTE): a multicentre, open-label, single-arm study:

Prof Andrew Menzies-Gow, MD Prof Mark Gurnell, PhD Prof Liam G Heaney, MD Jonathan Corren, MD Prof Elisabeth H Bel, MD Jorge Maspero, MD et al.

24 October, 2021

NZ Respiratory Research Review Issue 194

Prevalence, Deaths, and Disability-Adjusted Life-Years Due to Asthma and Its Attributable Risk Factors in 204 Countries and Territories, 1990-2019:

Saeid Safiri, PhD Kristin Carson-Chahhoud, PhD Nahid Karamzad, PhD Mark J.M. Sullman, PhD Seyed Aria Nejadghaderi, MD Ali Taghizadieh, MD Arielle Wilder Bell, MSW Ali-Asghar Kolahi, MD Khalil Ansarin, MD Mohammad Ali Mansournia, PhD Gary S. Collins, PhD Jay S. Kaufman, PhD

23 October, 2021

NZ Respiratory Research Review Issue 200

The cost-effectiveness of as-needed budesonide-formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in Canada:

Mohsen Sadatsafavi, J. Mark FitzGerald, Paul M. O’Byrne, Mena Soliman, Niroshan Sriskandarajah, Colin Vicente & Sarowar Muhammad Golam

12 October, 2021

NZ Respiratory Research Review Issue 194

Oral corticosteroids stewardship for asthma in adults and adolescents: A position paper from the Thoracic Society of Australia and New Zealand:

John Blakey,Li Ping Chung,Vanessa M. McDonald,Laurence Ruane,John Gornall,Chris Barton,Sinthia Bosnic-Anticevich,John Harrington,Mark Hew,Anne E. Holland,Trudy Hopkins,Lata Jayaram,Helen Reddel,John W. Upham,Peter G. Gibson,Philip Bardin

29 September, 2021

NZ Respiratory Research Review Issue 194

A randomised controlled trial of the effect of a connected inhaler system on medication adherence in uncontrolled asthmatic patients:

Alison Moore, Andrew Preece, Raj Sharma, Liam G. Heaney, Richard W. Costello, Robert A. Wise, Andrea Ludwig-Sengpiel, Giselle Mosnaim, Jamie Rees, Ryan Tomlinson, Ruth Tal-Singer, David A. Stempel, Neil Barnes

4 June, 2021

NZ Respiratory Research Review Issue 188

The inflammatory profile of exacerbations in patients with severe refractory eosinophilic asthma receiving mepolizumab (the MEX study): a prospective observational study:

P Jane McDowell, MRCP Sarah Diver, MRCP Freda Yang, MRCP Catherine Borg, MSc John Busby, PhD Vanessa Brown, PhD Rahul Shrimanker, MRCP Ciara Cox, PhD Prof Christopher E Brightling, FMedSci Prof Rekha Chaudhuri, MD Prof Ian D Pavord, FMedSci Prof Liam G Heaney, MD on behalf of the Medical Research Council: Refractory Asthma Stratification Programme (RASP-UK Consortium)

7 May, 2021

NZ Respiratory Research Review Issue 188

A low exhaled nitric oxide level excludes a short-term benefit from inhaled corticosteroids in suspected asthma: A randomized placebo-controlled trial:

Lissa Sutherland, Karen Shaw, Clair Parrish, Nicola Singleton, Tricia M. McKeever, Iain Stewart, Dominick Shaw, Matthew J. Martin, Tim Harrison

3 May, 2021

NZ Respiratory Research Review Issue 188

Longitudinal monitoring of asthma in the clinic using respiratory oscillometry:

Alice M. Cottee,Leigh M. Seccombe,Cindy Thamrin,Tanya Badal,Gregory G. King,Matthew J. Peters,Claude S. Farah,

1 April, 2021

NZ Respiratory Research Review Issue 188

Long-term prognosis of new adult-onset asthma in obese patients:

Pinja Ilmarinen, Adrienn Pardo, Leena E. Tuomisto, Iida Vähätalo, Onni Niemelä, Pentti Nieminen, Hannu Kankaanranta

1 April, 2021

NZ Respiratory Research Review Issue 188

Expert Consensus on the Tapering of Oral Corticosteroids for the Treatment of Asthma. A Delphi Study:

Carey M Suehs, Andrew Menzies-Gow, David Price, Eugene R. Bleecker, Giorgio Walter Canonica, Mark Gurnell and Arnaud Bourdin

1 April, 2021

NZ Respiratory Research Review Issue 194